Aisling Capital Partners III LLC, 10% Owner at Durata Therapeutics, Inc. (DRTX), bought 3,130,824 shares at $9.00 ($10.0M) on 2012-07-24, disclosed to the SEC on 2012-07-25.
Open-market purchase of $10.0M DRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,019,713 | $0 | 0.0% |
| 2 | $9.00 | 1,111,111 | $10.0M | 100.0% |
| Total | $3.19 avg | 3,130,824 | $10.0M | 100% |
| Filing → |
| LOXO | BUY | 2016-05-19 | $5.0M | — | Filing → |
| TTOO | BUY | 2015-12-09 | $3.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |